1. Market Research
  2. > Healthcare
  3. > Medical Device
  4. > In Vitro Diagnostics Market Trends
The Top 600 In-Vitro Diagnostics Companies Worldwide

The Top 600 In-Vitro Diagnostics Companies Worldwide

  • January 2017
  • 1051 pages
  • ID: 4651100

Summary

Did you know?

- Transasia Bio-Medicals is India’s largest in-vitro diagnostics company.
- Diachel SA is the leading independent in-vitro diagnostics distributor in Greece, offering complete laboratory solutions, from sales to after-sales support and service.
- Una Health Ltd., the fastest growing diagnostics distributor in the United Kingdom, specialises in bringing innovative point-of-care devices to the market.
- Abbott Diagnostics is #1 in immunoassay and blood screening worldwide.
- OraSure Technologies, Inc. has 327 employees.
- Marcel van Kasteel is Vice President & General Manager at Philips Handheld Diagnostics.
- OvaGene is unlike any other molecular diagnostics company; their only focus in on women's pelvic cancers and related conditions.
- In June, 2016, GenMark achieved the CE Mark for its ePlex sample-to-answer multiplex molecular diagnostics System and ePlex Respiratory Pathogen (RP) Panel.
- Trinity Biotech plc has point-of-care revenues of $20.0 million.
- Genetic Signatures is seeking to enter the U.S. market with strategic customer relationships and partnerships.
- Micronics, Inc., a leading developer of near-patient point-of-care in vitro diagnostics products, is a wholly owned subsidiary of Sony Corporation of America.
- In October, 2016, British distributor, YouMed Ltd. announced an agreement with Mobidiag Ltd., a Finnish molecular diagnostics company, to became an agent for Mobidiag’s Amplidiag® in-vitro diagnostic tests and compatible system for the detection of gastrointestinal infections.

These are just a tiny sample of the 1,000's of facts to be found in ‘The Top 600 In-Vitro Diagnostics Companies Worldwide’.

This unique and comprehensive report (1,051 pages) identifies and profiles the leading 600 manufacturers and distributors of core laboratory, point-of-care and molecular diagnostics. They are located right across the globe from the United States and Europe to India and China.

Profile information for companies in ‘The Top 600 In-Vitro Diagnostics Companies Worldwide’ includes:

- Company Contact Information - Address, Telephone and Fax Numbers, Email and Website Addresses
- Key Company Decision Makers - From CEO and Main Board, to Key Senior Managers
- Specialised fields such as Company Description, Products, Manufacturers Represented, Clinical Specialties/Diseases, Countries Served, Year Established, Number of Employees, Revenue ($U.S. million), Parent Company, Location Status, Ownership, Stock Exchange/Ticker Symbol

Report Target Market:

1) IVD Manufacturers
2) IVD Suppliers
3) IVD Distributors
4. IVD Industry Associations

Note: Most people will be aware of some of the major IVD companies such as Abacus ALS, Axon Lab, EKF Diagnostics, Nova Biomedical, Onkogen Diagnostik and QIAGEN but this major new report looks at all 600 of the top IVD companies worldwide - companies like:

- Sekisui Diagnostics - Sekisui Diagnostics is a diverse company with broad product lines, a global sales and distribution network, extensive product development capabilities, state of the art manufacturing facilities and deep diagnostics expertise. Over 1.5 billion tests are performed each year using the Company’s clinical chemistry products. Sekisui Diagnostics is headquartered in Lexington, MA, United States, has annual revenue of $175.0 million and over 525 employees worldwide. The Company is led by Bob Schruender, President and Chief Operating Officer. Sekisui Diagnostics is a member of AdvaMedDX.

- Inter Medico - Founded in 1979 by Dan Lichtman, President, Inter Medico is the largest Canadian-owned distributor of in-vitro diagnostics. The Company has strategic alliances with world-class manufacturers including Abbott Molecular, Biokit, Cepheid, Dako, Grifols, Helena Laboratories, Immunodiagnostic Systems, Inova Diagnostics, Siemens Healthcare and Trinity Biotech. Inter Medico’s products can be found in Canadian hospitals, reference laboratories, universities, and the biopharmaceutical industry.

- Chembio Diagnostic Systems, Inc. - Headquartered in Medford, New York, United States, Chembio Diagnostic Systems, Inc. (Nasdaq: CEMI) develops, manufactures, licenses and markets point-of-care diagnostic tests and technology for the detection of infectious diseases. The Company’s Dual Path Platform (DPP®) technology is providing it with a significant pipeline of business opportunities for the development and manufacture of new products. On November 3, 2015 Chembio announced plans to commercialise multiple combination DPP® Malaria Assays to identify plasmodium falciparum and other plasmodium infections. Founded in 1985, Chembio had revenues of $U.S. 27.6 million in 2014. It currently has 166 employees and is led by John J. Sperzel, Chief Executive Officer.

- Triolab AS - Founded in 1991, Danish company Triolab AS offers an extensive product range from point-of-care testing to full automation of clinical laboratories in the fields of coagulation, haematology, clinical chemistry, transfusion and transplantation diagnostics, molecular diagnostics and microbiology. The Company represents many leading diagnostics products manufacturers and has customers in all healthcare segments, from small clinical laboratories to large laboratory centres and hospital departments Triolab is part of the Swedish Addtech Group and has sister companies in Finland, Norway and Sweden. Together they are one of the leading diagnostic suppliers in the Nordic area. Triolab is led by Finn Ulbæk Andersen, Managing Director.

- Biocartis Group NV - Headquartered in Mechelen, Belgium, Biocartis Group NV is an innovative commercial stage, molecular diagnostics company providing next generation diagnostic solutions aimed at improving clinical practice for the benefit of patients, clinicians, payers and industry. The Company’s proprietary MDx Idylla™ platform is a fully automated, real time system which offers accurate, highly-reliable molecular information from any biological sample in virtually any setting. Idylla™ addresses the growing demand for personalized medicine by allowing fast and effective treatment selection and treatment progress monitoring. Biocartis Group NV is developing and marketing a rapidly expanding test menu addressing key unmet clinical needs in oncology and infectious diseases, the fastest and largest growing segments of the $U.S. 5.0 billion MDx market. The Company employs 300 people and had revenue of $U.S. 16.7 million in 2015. Biocartis Group NV has been listed on Euronext Brussels (BCART) since April 2015 and is led by Rudi Pauwels, Chief Executive Officer.

- Celtic Molecular Diagnostics (Pty) Ltd. - Founded in 2003, Celtic Molecular Diagnostics (Pty) Ltd. is a young, dynamic company providing high quality, innovative and affordable products to scientists in molecular research and diagnostic laboratories throughout Southern Africa. The Company aims to be a leading supplier of reagents and instrumentation in Southern Africa, through partnerships with prestigious manufacturers e.g. altona Diagnostics GmbH, Amoy Diagnostics Co., Ltd., Asuragen Inc., Invivoscribe, MRC-Holland, Primerdesign Ltd., Qnostics Ltd. and Sacace Biotechnologies Srl.. Celtic Molecular Diagnostics (Pty) Ltd. is led by Dermot Cox, Managing Director.

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 150+ Million searchable statistics with tables, figures & datasets
  • More than 25,000 trusted sources
  • Single User License — provides access to the report by one individual.
  • Department License — allows you to share the report with up to 5 users
  • Site License — allows the report to be shared amongst all employees in a defined country
  • Corporate License — allows for complete access, globally.
Ahmad helps you find the right report:
Testimonials

The research specialist advised us on the best content for our needs and provided a great report and follow-up, thanks very much we shall look at ReportLinker in the future.

Kate Merrick

Global Marketing Manager at
Eurotherm by Schneider Electric

We were impressed with the support that ReportLinker’s research specialists’ team provided. The report we purchased was useful and provided exactly what we want.

Category Manager at
Ikea

ReportLinker gave access to reliable and useful data while avoiding dispersing resources and spending too much time on unnecessary research.

Executive Director at
PwC Advisory

The customer service was fast, responsive, and 100% professional in all my dealings (...) If we have more research needs, I'll certainly prioritize working with ReportLinker!

Scott Griffith

Vice President Marketing at
Maurice Sporting Goods

The research specialist provided prompt, helpful instructions for accessing ReportLinker's product. He also followed up to make sure everything went smoothly and to ensure an easy transition to the next stage of my research

Jessica P Huffman

Research Associate at
American Transportation Research Institute

Excellent customer service. Very responsive and fast.

Director, Corporate Strategy at
Ingredion

I reached out to ReportLinker for a detailed market study on the Air Treatment industry. The quality of the report, the research specialist’s willingness to solve my queries exceeded my expectations. I would definitely recommend ReportLinker for in-depth industry information.

Mariana Mendoza

Global Platform Senior Manager at
Whirlpool Corporation

Thanks! I like what you've provided and will certainly come back if I need to do further research works.

Bee Hin Png

CEO at
LDR Pte Ltd

The research specialist advised us on the best content for our needs and provided a great report and follow-up, thanks very much we shall look at ReportLinker in the future.

Kate Merrick

Global Marketing Manager at
Eurotherm by Schneider Electric

FAQ
  • How we can help
    • I am not sure if the report I am interested in will fulfill my needs. Can you help me?
    • Yes, of course. You can call us at +33(0) 4 37 65 17 03 or drop us an email at researchadvisor@reportlinker.com to let us know more about your requirements.
    • We buy reports often - can ReportLinker get me any benefits?
    • Yes. Set up a call with a Senior Research Advisor to learn more - researchadvisor@reportlinker.com or +33(0) 4 37 65 17 03.
    • I have had negative experiences with market research reports before. How can you avoid this from happening again?
    • We advise all clients to read the TOC and Summary and list your questions so that we can get more insight for you before you make any purchase decision. A research advisor will accompany you so that you can compare samples and reports from different sources, and choose the study that is right for you.

  • Report Delivery
    • How and when I will receive my Report?
    • Most reports are delivered right away in a pdf format, while others are accessed via a secure link and access codes. Do note that sometimes reports are sent within a 12 hour period, depending on the time zones. However, you can contact us to escalate this. Should you need a hard copy, you can check if this option is offered for the particular report, and pay the related fees.
  • Payment conditions
    • What payment methods do you accept?
      1. Credit card : VISA, American Express, Mastercard, or
      2. You can download an invoice to pay by wire transfer, check, or via a Purchase Order from your company, or
      3. You can pay via a Check made out in US Dollars, Euros, or British Pounds for the full amount made payable to ReportLinker
    • What are ReportLinker’s Payment Terms?
    • All payments must normally be submitted within 30 days. However, you can let us know if you need extended time.
    • Are Taxes and duties included?
    • All companies based in France must pay a 20% tax per report. The same applies to all individuals based in the EU. All EU companies must supply their VAT number when purchasing to avoid this charge.
    • I’m not satisfied. Can I be refunded?
    • No. Once your order has been processed and the publisher has received a notification to send you the report, we cannot issue any refund or cancel any order. As these are not ‘traditional’ products that can be returned, reports that are dispatched are considered to be ‘consumed’.
  • User license
    • The license that you should acquire depends on the number of persons that need to access the report. This can range from Single User (only one person will have the right to read or access the report), or Department License (up to 5 persons), to Site License (a group of persons based in the same company location), or Corporate License (the entire company personnel based worldwide). However, as publishers have different terms and conditions, we can look into this for you.
Purchase Reports From Reputable Market Research Publishers
2019-2023 Germany Molecular Diagnostic Analyzers and Reagents: Market Share Analysis, Country Segment Forecasts, Competitive Intelligence, Technology Trends, Opportunities for Suppliers

2019-2023 Germany Molecular Diagnostic Analyzers and Reagents: Market Share Analysis, Country Segment Forecasts, Competitive Intelligence, Technology Trends, Opportunities for Suppliers

  • $ 2750
  • December 2018

2019-2023 Germany Molecular Diagnostic Analyzers and Reagents: Market Share Analysis, Country Segment Forecasts, Competitive Intelligence, Technology Trends, Opportunities for SuppliersThis new 1,125-page ...

2019-2023 US Molecular Diagnostic Analyzers and Reagents: Market Share Analysis, Country Segment Forecasts, Competitive Intelligence, Technology Trends, Opportunities for Suppliers

2019-2023 US Molecular Diagnostic Analyzers and Reagents: Market Share Analysis, Country Segment Forecasts, Competitive Intelligence, Technology Trends, Opportunities for Suppliers

  • $ 3850
  • December 2018

2019-2023 US Molecular Diagnostic Analyzers and Reagents: Market Share Analysis, Country Segment Forecasts, Competitive Intelligence, Technology Trends, Opportunities for SuppliersThis new 1,157-page report ...

US In Vitro Diagnostics Industry 2019-2023: Supplier Shares by Test, Segment Volume and Sales Forecasts, Instrumentation Review, Opportunities for Suppliers

US In Vitro Diagnostics Industry 2019-2023: Supplier Shares by Test, Segment Volume and Sales Forecasts, Instrumentation Review, Opportunities for Suppliers

  • $ 4350
  • December 2018

US In Vitro Diagnostics Industry 2019-2023: Supplier Shares by Test, Segment Volume and Sales Forecasts, Instrumentation Review, Opportunities for SuppliersThis new report provides an overview of the US ...


ref:plp2017

Reportlinker.com © Copyright 2018. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.

Make sure you don’t miss any news and follow us on